1.TAB. FOLIC ACID 5 MG 2.Cap/Tab. Calcium Dobesilate 500mg

Only those firms shall be eligible for placement of the purchase order whose products are registered with the Railway Board Directorate of Health

THE DRUGS/ MEDICINES/SURGICAL ITEMS MUST HAVE 80% SHELF LIFE AT THE TIME OF SUPPLY

HSN code must be mentioned during quoting of tender.

To comply with RB No. 2018/H/4/1/DP (Policy) dated 27.01.2020, the manufacturer/supplier must mention the name and complete address of a retail shop/pharmacy located within a radius of 200 km, due to remote location of MCF, from where the concerned drug/medicine can be purchased in the open market.

Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.

Consignee after receipt at MCF/RBL Hospital.

1) Delivery Terms: Free at Destination. 2)Mode of Dispatch/Delivery: by ROAD / RAIL. 3) Security Deposit NA. 4)CONSIGNEE: PCMO/MCF/RBL AT 4)CONSIGNEE: PCMO/MCF/RBL AT LALGANJ (UP) 229120. 5)EACH STRIP/PACKET/BOTTLE/CONTAINER THAT CONTAINS THE DRUG/MEDICINE/PRODUCTS SHOULD HAVE A ENDORSEMENT INDIAN RAILWAYS: NOT FOR SALE. 6) DRUG ANALYSIS REPORT FOR EACH BATCH FROM MANUFACTURERS OWN LABORATORY/GOVT. RECOGNIZED LABORATORY SHOULD BE SENT ALONG WITH THE SUPPLY FOR ACCEPTANCE OF DRUGS MEDICINE. 7) THE RAILWAY ADMINISTRATION RESERVES THE RIGHT TO TAKE SAMPLE OF ITEM FROM SUPPLIED PRODUCT FOR ANALYSIS. THE MATERIAL MAY BE SUBJECT TO TESTS IN RAILWAY/GOVT./GOVT. RECOGNIZED LABORATORY ON RANDOM BASIS OR WHENEVER FOUND NECESSARY BY THE CONCERNED CONSIGNEE. THE COST OF THE ANALYSIS WILL BE BORN BY THE SUPPLIERS IN CASE OF UNSATISFACTORY REPORTS .WHENEVER DRUGS SAMPLES ON ANALYSIS ARE FOUND NOT CONFIRMING TO STANDARD SPECIFICATION , THE SUPPLIER ARE REQUIRED TO REPLACE THE WHOLE QUANTITY FREE OF COST. IRRESPECTIVE OF WHETHER THE BATCH HAS BEEN USED COMPLETELY/PARTIALLY OR NOT. 8) MEDICINES SHOULD BE MANUFACTURED BY THE FIRM THEMSELVES WHICH MUST BE MENTIONED IN LABELLING/PACKING. IF THE PRINCIPAL FIRM IS MARKETING THE MEDICINE MANUFACTURED BY OTHER FIRM THE NAME OF PRINCIPAL FIRM MUST BE ENDORSED ON THE PACKING OF THE PRODUCT. 9) THE PACKING OFFERED SHOULD BE SUCH AS TO WITHSTAND ROUGH HANDING, TRANSPORTATION AND EXPOSURE TO EXTREME TEMPERATURE AND CLIMATIC CONDITION. 10) THE PRODUCT/MEDICINE /DRUGS REQUIRED IN PROPER SAFE PACKING AND IN LOOSE PACKING WILL NOT BE ACCEPTED. 11) THE SUPPLIER MUST MENTION THE BANK ACCOUNT NUMBER, IFSC CODE, ALONG WITH NAME OF BRANCH OF THE BANK IN OFFER AS WELL AS IN THE BILL. 12) DRUGS/PRODUCTS OF HUMAN ORIGIN SHOULD ALSO HAVE A CERTIFICATION STATING: FREE FROM HIV, HEPATITIS B AND HEPATITIS C AND E, ANTI HAEMOLYTIC FACTORS IMMUNOGLOBULIN, HUMAN ALBUMIN ETC. 13) ALL REJECTED ARTICLES MUST BE REMOVED BY THE SUPPLIERS AT THEIR OWN RISK AND COST WITHIN 14 DAYS OF REJECTION NOTICE. IF THE REJECTED MATERIAL IS NOT REMOVED WITHIN THE SPECIFIED PERIOD, THE RAILWAY SHALL AT LIBERTY TO RETURN THE MATERIAL IS ON FREIGHT PAID BASIS TO THE FIRM AND FREIGHT PAID BY RLY. WILL BE RETURNED FOR FIRM WITHOUT ANY FURTHER REFERENCE. IF IN OPINION OF THE INSPECTING OFFICERS, THE MATERIAL IS NOT WORTH RETURNING THE SAME SHALL BE THROWN AWAY OR THE SAME SHALL BE THROWN AWAY OR DESTROYED. NO CLAIM OF COST AND COMPENSATION WILL BE ENTERTAINED AGAINST THESE ITEMS.

14) THE CONTRACT WITH THE STOCKIST/AUTHORIZED IMPORTER WILL REMAIN VALID TILL SUCH AUTHORIZATION EXISTS AND IN THE EVENT OF DISCONTINUATION OF AUTHORIZATION BY THE PRINCIPAL FIRM, THE CONTRACT WITH THE SUPPLIER WILL BE DEEMED TO HAVE TERMINATED AND FRESH P.O. WILL BE ISSUED IN FAVOUR OF NEW SUPPLIER APPOINTED BY THE PRINCIPAL. NO CONFIRMATION FROM THE DISTRIBUTOR/SUPPLIER IS NECESSARY IN THESE CASES.15) PRICE VARIATION CLAUSE WILL NOT BE ACCEPTABLE.16)INPUT TAX CREDIT: IN CASE YOU AVAIL ITC AGAINST GST & CORRESPONDING ADDITIONAL BENEFITS ON THIS ACCOUNT, IF ANY TO BE PASSED ON TO PURCHASER.17) WHENEVER DRUG SAMPLES ON ANALYSIS ARE FOUND TO BE NOT CONFORMING TO STANDARDS, THE FIRMS/ SUPPLIERS ARE REQUIRED TO REPLACE THE WHOLE BATCH FREE OF COST WITH ANOTHER BATCH TO THE CONSIGNEES, IRRESPECTIVE OF WHETHER THE BATCH HAS BEEN USED COMPLETELY/ PARTIALLY OF NOT.18) LIQUIDATED DAMAGE (LD) ON DELAYED SUPPLY: RECOVERY OF LIQUIDATED DAMAGE (LD) SHALL BE LEVIED @1/2% (HALF PERCENT) OF THE PRICE OF THE DELAYED STORE PER WEEK OR PART OF THE WEEK DURING WHICH DELIVERY IS ACCEPTED AND THE UPPER LIMIT FOR RECOVERY OF LD IN SUPPLY CONTRACTS IS 10% (TEN PERCENT) OF THE VALUE OF CONTRACT IRRESPECTIVE OF DELAYS, UNLESS OTHERWISE PROVIDED, SPECIFICALLY IN THE CONTRACT.